🇺🇸 FDA
Patent

US 7645775

Triazoles useful as inhibitors of protein kinases

granted A61PA61P1/00A61P1/16

Quick answer

US patent 7645775 (Triazoles useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P1/16, A61P11/06, A61P13/12